19:54:35 EDT Thu 09 May 2024
Enter Symbol
or Name
USA
CA



Navco Pharmaceuticals Inc
Symbol NAV
Shares Issued 57,069,541
Close 2024-04-12 C$ 0.025
Market Cap C$ 1,426,739
Recent Sedar Documents

Navco hires SOF Marketing for $300,000

2024-04-12 18:15 ET - News Release

Mr. Geoffrey Lee reports

NAVCO ANNOUNCES MARKETING CAMPAIGN

Navco Pharmaceuticals Inc. has entered a contract with SOF Marketing for $300,000 to broaden the company's reach within the investment community, to increase investor awareness of the company, and to attract potential new investors through various on-line platforms and methods of engagement. The marketing services include project management, rebranding, social media marketing, consulting for an on-line marketing campaign, co-ordinating marketing actions, maintaining and optimizing adwords campaigns, adapting adwords bidding strategies, optimizing adwords ads, and creating and optimizing landing pages. The promotional activity will include e-mail, Facebook and Google and will last until Oct. 12, 2024.

About Navco Pharmaceuticals Inc.

Navco, based in Burlington, Ont., is a company that is building a leading market position in the use of nanotechnology to develop and commercialize novel products against bacteria, viruses, fungi and infectious diseases. Navco has a portfolio of patent-pending and Health Canada-approved products. The company's pipeline of applications is tailored to uniquely defend against pathogens utilizing new methods of action to capitalize on unmet health and product needs using natural and known compounds and nanoparticles with a high degree of efficacy. Target markets include human health and personal skin care, household and institutional products, and veterinary health.

We seek Safe Harbor.

© 2024 Canjex Publishing Ltd. All rights reserved.